A notable example is OMTX705, a novel humanized anti-fibroblast activation protein (FAP) antibody conjugated to cytolysin TAM470, which has demonstrated significant tumor regression and delayed progression in immunocompetent models resistant to programmed cell death protein 1 (PD-1) inhibition. Here, PDCD1 is linked to neoplasm.